The goal is for nine out of ten adults to be fully vaccinated. Norway has more than enough vaccine doses, but vaccination is slow.
The government and the National Institute of Public Health (NIPH) have a clear goal: 90 percent of all people over the age of 18 must be fully vaccinated against the coronavirus.
We do not depend on it being fulfilled. Norway has already opened. But the more people protect themselves, the lower the risk.
In recent months, Norway has had more than enough vaccine doses. In some places, unused doses are discarded. Oslo has canceled the doses.
Fewer will take dose two
Now it’s about making people want to get vaccinated.
More than 90 percent of all adults have already received a dose. Not many seem eager to take the second dose.
Aftenposten resolved the status three weeks ago. At that time, 77.1 percent of all adults were fully vaccinated. The message from FHI’s chief physician, Preben Aavitsland, was that it could be three to four weeks before the 90 percent goal is close.
Norway is open. But still 1.5 million Norwegians can spread the infection. What is needed for the measures to be reintroduced?
Behind the way
Three weeks later, only 84.6 percent are still fully vaccinated.
At the same time, municipalities have had to dispose of vaccine doses and NIPH has hundreds of thousands of doses in stock. Aftenposten wrote this on September 10.
Because people don’t show up for their classes. Some do not show up, others open the door when they are told they will receive the Moderna vaccine.
Optional vaccine type
There are mainly two reasons why people are skeptical with Moderna: people don’t want to mix two doses of vaccine and the second dose of Moderna produces stronger side effects in the following days.
– The opposition is irrational, said the head of infection control in Bergen Kjell Haug to NRK in early September.
FHI however, it has taken steps to vaccinate more people. The type of vaccine will now be optional.
It can have an effect on the timing of the vaccine.
Now the pace is slower than it has been for many months. Even with a shortage of doses, this spring they were stabbed more than now.
With over 200,000 over the age of 18 who have not been fully vaccinated, this is a sign that we have now reached out to those who are not as eager to get vaccinated.
If vaccination continues at the rate of the past two weeks, it will be 24 days before the vaccination goal is reached.
It is young adults who are left far behind. Up to 94 percent of all people over the age of 55 are fully vaccinated. Only 73 percent of those between the ages of 18 and 39 are fully vaccinated. This is shown in the latest FHI weekly report.
Vaccinate many young people
The coronary vaccine must first of all protect the individual against serious diseases. These have been the clear objectives of the government and FHI from the beginning.
Therefore, the proportion of vaccinated adults is measured. Adolescents very rarely get seriously ill. Now, however, the vaccine is also offered to children up to 12 years of age.
Many young people get vaccinated. Those under the age of 16 are currently offered only one dose.
Poor support among immigrants
Residents born outside of Norway, in particular, have low support for vaccines. This is shown in the FHI weekly reports.
Only 36.6 percent of those over the age of 18 born in Poland are fully vaccinated. For adults in Lithuania and Somalia, dose 2 support is 37.5 and 45.4 percent, respectively.
Half of all inmates from July to September 11 were foreign-born. Most were not vaccinated.
It may be the third dose of vaccine
Now it is speculated if the vaccine will lose effect with time. Approximately 300,000 people in Norway have been fully vaccinated for more than six months.
The time ahead will show how many of these will become infected and possibly seriously ill.
A cool Swede study shows that the level of antibodies dropped by 85 percent after seven months. Studies from other countries suggest the same.
However, FHI does not believe that there is sufficient basis to recommend a third dose.
FHI has already offered an additional dose to patients with severely weakened immune systems., who did not receive adequate protection from two doses. This applies to about 200,000 people in Norway.